Vimta Labs

Vimta Labs Interest Coverage

The Interest Coverage Ratio of Vimta Labs (VIMTALABS.NS) as of Oct 22, 2026 is 147.33. In the previous year, Interest Coverage Ratio was 342.39 — a change of -56.97% (lower).

Interest Coverage

147.33

YoY

-56.97%

Last updated:

Interest Coverage Ratio of Vimta Labs is 2025 147.33 . Interest Coverage Ratio of Vimta Labs was 2024 342.39 . It decreases by -56.97% lower compared to the previous year.

The Vimta Labs Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2018
6.99 INR
Jan 1, 2019
17.37 INR
Jan 1, 2020
11.99 INR
Jan 1, 2021
20.62 INR
Jan 1, 2022
49.09 INR
Jan 1, 2023
32.20 INR
Jan 1, 2024
342.39 INR
Jan 1, 2025
147.33 INR
The Vimta Labs Interest Coverage history
YEARInterest CoverageYoY
147.33-56.97%
342.39+963.26%
32.20-34.40%
49.09+138.11%
20.62+72.01%
11.99-30.99%
17.37+148.36%
6.99-40.04%
11.66+2.87%
11.34-7.93%
12.31-53.13%
26.27—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Vimta Labs Stock analysis

What does Vimta Labs do? Vimta Labs Ltd. provides contract research and testing services across multiple industries including biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, power, cement, oil and gas, ores and minerals, and infrastructure. The company serves biopharmaceutical firms, medical device companies, agrochemical and specialty chemical firms, food manufacturers, processors, farmers, retailers, hospitals, and government organizations. Its services include drug discovery, development, and life cycle management support; preclinical research for medical devices; contract research for agrochemical and specialty chemicals; food testing and analytical development; clinical diagnostics for patients and hospitals; and environmental regulatory services like impact assessments and post-project monitoring for power and infrastructure sectors. The primary buyers of Vimta Labs' services are biopharmaceutical companies requiring drug development support, medical device manufacturers needing preclinical testing, agrochemical firms seeking contract research, food industry stakeholders such as manufacturers and retailers, healthcare providers including hospitals, and government entities requiring environmental assessments. These segments represent the core revenue streams for the company through its specialized testing and research offerings. Vimta Labs generates revenue by delivering tailored research and testing solutions to industry-specific clients across diverse sectors. The company’s service portfolio targets key industries where regulatory compliance and product safety are critical, ensuring consistent demand for its analytical and diagnostic services. By maintaining a broad service range, Vimta Labs secures contracts with multiple industry participants, including government organizations, to sustain its business model. Vimta Labs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vimta Labs stock

Interest Coverage Ratio of Vimta Labs is 147.33 in 2025.

Interest Coverage Ratio of Vimta Labs changed from 342.39 to 147.33, representing a -56.97% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Vimta Labs since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Vimta Labs with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Vimta Labs

All Key Metrics — Vimta Labs